AzTrials
AzTrials

Preventive CarePARENTALIMNCT06184386

Oral Feeding Delay Prevention in Preterm Newborns

An observational study of Preventive Care, run by University Hospital, Caen at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Preventing oral feeding delays in preterm newborns remains a stake for NICU nowadays. Indeed, it lengthens hospitalization duration, distorts parent-newborns relationships, and increases the risks of adverse nursing outcomes. Read more about this study

Who is it for?
Ages 3 days to 10 weeks
Conditions the study is for
Preventive Care
What is being tested?
NIDCAPARENTALIM and SOFS
How many people
43 participants
Where
1 siteFrance
Study dates
2 Feb 2019to 15 Apr 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 days to 10 weeks
  • All sexes
  • Child

Study population: Preterm newborns born before 34 weeks of amenorrhea with variable but moderated neonatal risks and their parents.

Who may be able to join

  • Parents of preterm newborns born before 34 weeks of amenorrhea
  • Parents who agree participating in the study after signing an informed consent.
  • Minimal delay of 72 hours and maximal delay of 15 days after birth to inform parents and wait their consent.

Who cannot join

  • Parents of preterm newborns born after 35 weeks of amenorrhea
  • Parents who disagree participating in the study, even after signing the informed consent.
  • Parents of preterm newborns born with cerebral, maxillo-facial, digestive, cardiac, genetic or syndromic abnormalities.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Maryse Delaunay

    Caen, Normandy, 14000

Other trials in France

About this study

Official title: Efficiency of Parental Feeding Support to Strengthen NIDCAP and Favor Eating Development in Preterm Newborns as Compared With a Retrospective Orofacial Stimulation Standardized and Routine Clinical Practice

Preventing oral feeding delays in preterm newborns remains a stake for NICU nowadays. Indeed, it lengthens hospitalization duration, distorts parent-newborns relationships, and increases the risks of adverse nursing outcomes. Does a routine individualized developmental preventive feeding care implying parents favors earlier autonomous oral feeding achievement in preterm newborns as compared with a standardized routine program of orofacial stimulations, despite neonatal risks that every preterm newborn cumulates during hospitalization stay ?

Read the detailed description

The goal of this observational study is to compare the efficiency of two routine preventive feeding care in preterm newborns, taking into account neonatal cumulated risks for each preterm newborn participant. The main question it aims to answer is: Does a prospective individualized routine developmental preventive feeding care leads to earlier oral feeding achievement in preterm newborns despite individual risks, as compared with a retrospective standardized routine program. The group of preterm newborns prospectively assigned in the study will be included in NIDCAP strengthen with a parental support on nursing care named PARENTALIM. The group of preterm newborns retrospectively assigned in the study received orofacial stimulations in a standardized protocol way (SOFS) Researchers will compare prospective and retrospective groups to see if the prospective group achieve autonomous oral feeding, despite individual neonatal cumulated risks, significantly earlier than retrospective group.

Conditions
Preventive Care
Being tested
NIDCAPARENTALIM, SOFS
Keywords
preterm newborns, individualized developmental care, parental suppport for nursing, orofacial stimulations, oral feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NIDCAPARENTALIMOther

    PARENTALIM practice that strengthens the NIDCAP. It is proposed in a routine way in the NICU since 2019. PARENTALIM supports and monitors parental implication in nursing care. It is led by a speach language therapist specialized in early feeding development who proposes 5 individualized interviews and uses an educational booklet on eating development care with a lot of illustrations and few words.

  • SOFSBehavioural

    SOFS is a behavioral practice of orofacial stimulations. Il has been mainly carried out by nurses or a speach language therapist specialized in early feeding development. SOFS has been applied through routine protocol in the NICU until 2018.

Study groups in NCT06184386
Study groupRoleWhat they receive
Prospective NIDCAPARENTALIMA group of prospectively assigned preterm newborns that will be included in NIDCAP strengthened with a practice focalized on feeding, named PARENTALIM.
Receives: Other: NIDCAPARENTALIM
Retrospective SOFSA group of retrospectively assigned preterm newborns that had standardized orofacial stimulations named SOFS.
Receives: Behavioral: SOFS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The precocity of autonomous oral feeding achievement taking into account the index of cumulated neonatal risks

    The corrected age in ammenorhea weeks at which preterm newborn achieve autonomous oral feeding will be divided by the index of cumulated neonatal risks scored from the updated risk inventory initially proposed by Sheiner and Sexton in 1991

    Measured: 5 years

Secondary outcomes (1)
  1. The duration of oral feeding transition

    The duration from the moment when preterm newborn takes 5 ml per kg per day and until the moment when autonomous oral feeding is achieved.

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2023
  2. Study start2 Feb 2019
  3. Primary completion11 Feb 2019
  4. Study completion15 Apr 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Other
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06184386
Sponsor's protocol ID
20-161
Acronym
PARENTALIM
Status last verified
Dec 2023
First submitted
14 Dec 2023
Last updated
28 Dec 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Preventive Care, run by University Hospital, Caen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The precocity of autonomous oral feeding achievement taking into account the index of cumulated neonatal risks (time frame: 5 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in